Timothy V. Olah is originally from Fords, NJ. He
graduated from Princeton University, Princeton, NJ in 1979 with a B.A. degree in
Chemistry and three varsity letters in basketball.
After spending one year
studying organic synthetic chemistry as a post-graduate at Washington University
in St. Louis and three years as a Laboratory / Research Technician at St. Louis
Children’s Hospital, he returned to graduate school on the east coast.
He graduated from the
University of Pennsylvania, Philadelphia, PA in 1989 with a Ph.D. in Biological
Chemistry and joined the Department of Drug Metabolism at the Merck Research
Laboratories in West Point, PA where he helped in establishing an LC/MS-based
bioanalytical group. His supervisor was the late Dr. John D. Gilbert.
In July 2000, he joined the
DuPont Pharmaceuticals Company in their Bioanalytical/Structural Chemistry group
in the Department of Drug Metabolism and Pharmacokinetics .
Following the purchase of
DuPont Pharmaceuticals by the Bristol-Myers Squibb Company in 2001, he was
appointed the Director of Bioanalytical Research in their Pharmaceutical
His research centers on the
development of rapid, accurate, and precise multiple component bioanalytical
methods using automated liquid handling systems and liquid chromatography mass
spectrometry detection to support pharmaceutical research and development in all
aspects of drug discovery and development at BMS.